Jefferies Group’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-654,300
Closed -$139M 2701
2014
Q4
$139M Sell
654,300
-307,200
-32% -$61.1M 0.82% 14
2014
Q3
$171M Buy
961,500
+679,600
+241% +$113M 1.17% 8
2014
Q2
$47.7M Buy
281,900
+241,900
+605% +$37.7M 0.4% 49
2014
Q1
$4.96M Sell
40,000
-206,000
-84% -$25.1M 0.05% 310
2013
Q4
$27.3M Buy
246,000
+113,100
+85% +$10.8M 0.17% 61
2013
Q3
$12M Sell
132,900
-500
-0.4% -$44.9K 0.12% 145
2013
Q2
$11.2M Buy
+133,400
New +$13.8M 0.12% 126

Other funds holding AGN

Jefferies Group's AGN Position: Q1 2015 in Review

Jefferies Group sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 371,237 shares — an estimated $78.9M sold.

Jefferies Group first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $78.9M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Jefferies Group reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Jefferies Group sold 371,237 Allergan Inc shares in Q1 2015, an estimated $78.9M.
  • Jefferies Group first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Jefferies Group's Allergan Inc position peaked at $78.9M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Jefferies Group's 13F filing for Q1 2015, filed 18 May 2015.